Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Apr 2023 - Mar 2024
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
ViiV Healthcare Limited (ViiV)
EU Transparency Register
062557939516-27 First registered on 10 Sep 2020
Goals / Remit
ViiV Healthcare was established to take a fresh approach to the challenge of HIV. We set ourselves one mission - to leave no person living with HIV behind.
Our values and expectations are at the heart of everything we do. They are integral to how we conduct our business and form an important part of our culture.Main EU files targeted
For those diagnosed and treated early, HIV is now a long-terms, rather than fatal, condition. With our policy and advocacy activities we hope to address the needs generated by increased life expectancy, by looking to improve health outcomes and quality of life of people living with HIV in the long-term. As such the key reccomendations we are supporting are as follows:
1 Adopt an integrated, outcomes-focused and patient-centred approach to long-term HIV care
2 Expand national monitoring of long-term HIV care and outcomes
3 Fund cohort studies to provide information on the long-term health of people living with HIV
4 Combat stigma and discrimination within health systems
5 Upscale involvement of the HIV community in priority setting at country level
additionally the EU initiatives that we are trying to inform include:
1. Pharmaceutical Strategy
2. IP action plan
3. European Health UnionAddress
Head Office
980 Great West Road Middlesex
Brentford TW8 9GS
UNITED KINGDOMEU Office
980 Great West Road Middlesex
Brentford TW8 9GS
UNITED KINGDOMWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
HIV Outcomes - https://hivoutcomes.eu/
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Apr 2023 - Mar 2024
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount acumen public affairs srl 200,000€ - 299,999€ Intermediaries for current year
Name fipra international srl Closed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Roundtable discussion on achieving the end of HIV by 2030 and the role of Innovation, input into consultations (including EFPIA and GSKs position) on EU policy position on the aforementioned priority areas ( EU General Pharmaceutical Legislation, cultivate policy champions for HIV treatment and prevention ahead of and post EU elections, inform the EU commissions (DG SANTE) priorities on health and HIV in particular
Other activities
None declared
- Meetings
Meetings
None declared
- Meetings